|
2024
|
Invention
|
Treatment of intervertebral disc degeneration.
A method for preventing or retarding degeneration... |
|
2023
|
Invention
|
Treatment of intervertebral disc degeneration and discogenic back pain.
A method for preventing ... |
|
|
Invention
|
Treatment of intervertebral disc degeneration and discogenic back pain.
A method for restoring a... |
|
|
Invention
|
Method for assessing validity of cell therapy product.
A composition according to an embodiment ... |
|
2021
|
Invention
|
Composition for treating inflammatory disease induced by hyperimmune response.
A composition acc... |
|
|
Invention
|
Treatment of spinal cord injury with pten inhibitor.
The present application discloses method of... |
|
|
Invention
|
Treatment of spinal cord injury with pten inhibitor. The present application discloses method of ... |
|
|
Invention
|
Nerve regeneration.
The present application describes a method of regenerating nerve, which step... |
|
|
Invention
|
Cartilage regeneration using chondrocyte and tgf-beta.
The present application is directed to a ... |
|
|
Invention
|
Mixed-cell gene therapy.
The subject invention is directed to a mixed cell composition to genera... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of arthritis and orthopedic disorders; veterinary p... |
|
2020
|
Invention
|
Treatment of intervertebral disc degeneration.
The present application discloses a method for pr... |
|
|
Invention
|
Cartilage regeneration using chondrocyte and tgf-β. The present application is directed to a meth... |
|
|
Invention
|
Mixed-cell gene therapy. The subject invention is directed to a mixed cell composition to generat... |
|
|
Invention
|
Treatment of intervertebral disc degeneration. The present application discloses a method for pre... |
|
|
Invention
|
Treatment of damaged nerve with pten inhibitor.
The present application discloses a method of gr... |
|
2018
|
Invention
|
Method for assessing validity of cell therapy product. The present invention provides a method fo... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating osteoarthritis. The present invention relat... |
|
|
Invention
|
Method for assessing validity of cell therapy product. The present invention relates to a method ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of arthritis and orthopedic disorders |
|
2016
|
Invention
|
Treatment of damaged nerve with pten inhibitor. The present application discloses a method of gro... |
|
|
Invention
|
Composition for treating inflammatory disease induced by hyperimmune response. Provided is a cell... |
|
2015
|
P/S
|
Pharmaceutical preparations for the treatment of
osteoarthritis. |
|
2009
|
Invention
|
Primed cell therapy. The subject invention is directed to a composition comprising primed connect... |
|
2008
|
Invention
|
Osteogenic differentiation of preosteoblastic cells.
The application discloses a method for maki... |
|
2003
|
Invention
|
Cartilage regeneration using chondrocyte and tgf-beta. The present application is directed to a m... |
|
|
Invention
|
Bioadhesive directed somatic cell therapy. The subject invention is related to a cell-mediated ge... |
|
2000
|
Invention
|
Gene therapy using tgf-β. The subject invention is related to a cell-mediated gene therapy treatm... |
|
|
Invention
|
Gene therapy using tgf-β . The subject invention is related to a cell-mediated gene therapy treat... |
|
1999
|
Invention
|
Generating cartilage in a mammal using fibroblasts transfected with a vector encoding tgf-.beta.-... |
